Abstract
On March 24th 1882 Koch’s announcement in Berlin of the discovery of the microbial cause of tuberculosis (TB), Mycobacterium tuberculosis, heralded a major breakthrough, bringing hope for a devastating disease which at that time caused the death of one in seven people in Europe and the Americas. (Wallstedt and Maeurer, 2015). One hundred and twenty years later, and despite the availability of effective treatment for the past 6 decades, 1.4 million people die of TB annually (WHO, 2021a). Over the past 15 months, the unprecedented COVID-19 pandemic has disrupted health services globally (Cilloni et al., 2020) and has negatively impacted on gains being made in global TB control efforts to achieve End TB targets (Sahu et al., 2020; STOP TB, 2019).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.